Pricing Log in Create free account

Alvotech (ALVO) vs Xeris Biopharma Holdings, Inc. (XERS)

Alvotech and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Xeris Biopharma Holdings, Inc. is the larger, with a market value of $2.4B against $1.8B — 1.3× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against 38.4%. Xeris Biopharma Holdings, Inc. has the higher net margin (−1.76% vs −101.1%) and the higher return on invested capital (27.2% vs 0.00%). Across the 16 metrics below, Xeris Biopharma Holdings, Inc. leads on 10 and Alvotech on 6.

Valuation

Metric ALVO XERS Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 4.60 6.36 2.08
P/B n/m 48.03 1.79
Price to free cash flow n/m 32.23 16.29
EV/EBITDA n/m 46.61 12.22
EV/Sales 8.56 6.70 2.87
Earnings yield (26.12%) (0.31%) (15.94%)
Free cash flow yield (15.71%) 3.10% 0.00%

Profitability

Metric ALVO XERS Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 87.38% 53.51%
Operating margin (42.43%) 12.70% 0.00%
Net margin (101.05%) (1.76%) (2.45%)
Free cash flow margin 0.00% 20.00% 0.00%
Return on equity 0.00% (27.11%) (0.80%)
Return on assets 0.00% (1.64%) (1.67%)
Return on invested capital 0.00% 27.22% 0.00%

Growth

Metric ALVO XERS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% 38.37% 5.22%
EPS growth (last fiscal year) 111.49% 100.86% 42.91%
Revenue growth, 5-year CAGR — 70.20% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO XERS Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 3.89 0.04
Current ratio 1.65 2.15 2.41
Net debt to EBITDA 9.71 2.67 1.01

Dividend

Metric ALVO XERS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ALVO XERS Drug Manufacturers Specialty & Generic median
Market cap 1.78b 2.38b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack